ARUNA BIO INC.

In News

Exosomes: Company Spotlights from "A" to "Z" - BioInformant

BioInformant - Nov 04, 2025

Aruna Bio secures US patent for exosome-derived neuroinflammation treatment - Healio

Healio - Aug 20, 2024

Aruna Miller promotes Maryland as a national hub for life sciences - The American Bazaar

The American Bazaar - Jun 19, 2025

Robotic surgery heats up with clearances and clinical trials - Modern Healthcare News

Modern Healthcare News - Aug 19, 2025

Aruna Bio’s Exosome AB126 Cleared for US Trial in Acute Ischemic Stroke - CGTLive®

CGTLive® - Jan 23, 2024

Vicarious Surgical Appoints Stephen From CEO - citybiz

citybiz - Jul 31, 2025

Mary M. Worthington Obituary April 19, 2025 - McGuire & Davies Funeral Home and Crematory

McGuire & Davies Funeral Home and Crematory - Apr 19, 2025

Medtech firms shuffle execs in 2025 - MedTech Dive

MedTech Dive - Aug 25, 2025

Aruna Bio’s AB126 eased inflammation in ALS mouse model - ALS News Today

ALS News Today - Sep 12, 2023

Aruna Bio Announces FDA Clearance of IND for Lead Program AB126, Enabling the First Exosome to Enter in Human Clinical Trials for a Neurological Indication - BioInformant

BioInformant - Apr 06, 2024

Whittier Daily News - FinancialContent

FinancialContent - Jul 31, 2025

Aruna Bio Announces Issuance of a New Composition of Matter Patent Covering Neural Exosomes in Japan - BioInformant

BioInformant - Jun 24, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment